Earnings Call · Q1 FY2026·2026-05-01

Q1 26EPS +8.89%·Rev n/aQ4 25EPS +12.50%·Rev n/aQ3 25EPS +2.17%·Rev n/aQ2 25EPS +11.36%·Rev n/a⚠ consensus missing

IRADIMED CORP IRMD

Roger Susi — CEO, President, Chairman

John Glenn — CHIEF FINANCIAL OFFICER

+4.4%1d on move date+4.2% vs SPY3d+2.9%5d+4.0%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IRMD calls or request research access.

More IRMD calls Browse calls Request research access